164 related articles for article (PubMed ID: 8622079)
1. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
Hainsworth JD; Jones SE; Mennel RG; Blum JL; Greco FA
J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
6. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
Jones SE; Mennel RG; Brooks B; Westrick MA; Allison MA; Paulson RS; Tilmann K; Rea B
J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxel.
Hainsworth JD
Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):4-9. PubMed ID: 9460336
[TBL] [Abstract][Full Text] [Related]
9. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
[TBL] [Abstract][Full Text] [Related]
10. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
Hainsworth JD
Ann Oncol; 1993; 4 Suppl 2():37-40. PubMed ID: 7688982
[TBL] [Abstract][Full Text] [Related]
11. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.
Hainsworth JD; Andrews MB; Johnson DH; Greco FA
J Clin Oncol; 1991 Oct; 9(10):1731-5. PubMed ID: 1919624
[TBL] [Abstract][Full Text] [Related]
13. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
Klaassen U; Harstrick A; Wilke H; Seeber S
Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH
Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer.
Nicholson BP; Paul DM; Hande KR; Shyr Y; Meshad M; Cohen A; Johnson DH
Clin Breast Cancer; 2000 Jul; 1(2):136-43; discussion 144. PubMed ID: 11899652
[TBL] [Abstract][Full Text] [Related]
16. Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer.
Klaassen U; Wilke H; Weyhofen R; Harstrick A; Eberhardt W; Müller C; Korn M; Hanske M; Diergarten K; Seeber S
Anticancer Drugs; 1998 Mar; 9(3):203-7. PubMed ID: 9625430
[TBL] [Abstract][Full Text] [Related]
17. Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin.
Venturino A; Comandini D; Simoni C; Merlini L; Naso C; Palumbo R; Fusco V; Porcile G; Pronzato P; Rosso R; Repetto L
Breast Cancer Res Treat; 2000 Apr; 60(3):195-200. PubMed ID: 10930106
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Calvert S; Greco FA
Cancer Invest; 2002; 20(7-8):863-71. PubMed ID: 12449715
[TBL] [Abstract][Full Text] [Related]
20. Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancer.
Klaassen U; Wilke H; Müller C; Borquez D; Korn M; Achterrath W; Harstrick A; Diergarten K; Seeber S
Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):38-40. PubMed ID: 9144690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]